Maryn Ugolini, BS

Elizabeth Kellom, MS, CGC

Gene Therapy vs. Cochlear Implantation in Restoring Hearing Function and Speech Perception for Individuals with Congenital Deafness

  • Describe mechanisms that contribute to OTOF-related congenital deafness (autosomal recessive deafness 9).
  • Evaluate benefits and limitations of gene therapy and cochlear implantation in the treatment of congenital deafness.
  • Identify changes in auditory and speech perception related to the implementation of gene therapy and cochlear implantation.
Session date: 
12/10/2025 - 4:00pm to 5:00pm CST
Location: 
Virtually
WI 53705
United States
See map: Google Maps
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 CDR CPEUs
  • 1.00 NSGC Category 1 CEU Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Maryn Ugolini, BS (grad student)
Elizabeth Kellom, MS, CGC